Insider Transactions in Q2 2022 at Veracyte, Inc. (VCYT)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2022
|
Evan/ Fa Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,731
+20.13%
|
-
|
|
Jun 16
2022
|
John L Bishop Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,731
+38.58%
|
-
|
|
Jun 16
2022
|
Muna Bhanji Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,731
+35.93%
|
-
|
|
Jun 16
2022
|
Karin Eastham Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,731
+38.58%
|
-
|
|
Jun 16
2022
|
Robert S Epstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,731
+38.58%
|
-
|
|
Jun 16
2022
|
Jens Holstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,731
+46.82%
|
-
|
|
Jun 14
2022
|
Jens Holstein Director |
SELL
Open market or private sale
|
Direct |
8,720
-81.34%
|
$139,520
$16.27 P/Share
|
|
Jun 10
2022
|
Marc Stapley Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
60,000
+27.3%
|
$960,000
$16.33 P/Share
|
|
Jun 08
2022
|
Kevin K Gordon Director |
SELL
Open market or private sale
|
Direct |
15,000
-63.24%
|
$270,000
$18.5 P/Share
|
|
Jun 08
2022
|
Kevin K Gordon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+38.74%
|
$105,000
$7.39 P/Share
|
|
Jun 02
2022
|
Giulia C Kennedy Chief Scientific & Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,008
-1.64%
|
$18,144
$18.23 P/Share
|
|
Jun 02
2022
|
Marc Stapley Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,047
-3.9%
|
$72,846
$18.23 P/Share
|
|
Jun 02
2022
|
Bonnie H Anderson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,042
-2.96%
|
$36,756
$18.23 P/Share
|
|
May 01
2022
|
Bonnie H Anderson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
736
-0.85%
|
$14,720
$20.47 P/Share
|